Trial Profile
Study on the Correlation Between the Treatment Effectiveness of Ranibizumab and the Role of the Cytokines in Macular Edema With Retinal Vein Occlusion
Status:
Recruiting
Phase of Trial:
Phase II
Latest Information Update: 06 Jul 2020
Price :
$35
*
At a glance
- Drugs Ranibizumab (Primary)
- Indications Branch retinal vein occlusion; Central retinal vein occlusion; Retinal oedema
- Focus Therapeutic Use
- 15 Jul 2014 New trial record